Treatment of withdrawal dyskinesia [3]

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 44, Issue 11, 2005, Pages 1102-1103

  Kafantaris, Vivian ^a   Hirsch, Judith ^a   Saito, Ema ^a   Bennett, Natasha ^a  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BRANCHED CHAIN AMINO ACID; ISOLEUCINE; LEUCINE; LITHIUM; NEUROLEPTIC AGENT; QUETIAPINE; TARVIL; UNCLASSIFIED DRUG; VALINE; VALPROATE SEMISODIUM;

ADOLESCENT; BIPOLAR I DISORDER; CASE REPORT; DYSPEPSIA; GASTROINTESTINAL SYMPTOM; HALLUCINATION; HUMAN; LETTER; MALE; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; SUICIDE ATTEMPT; TARDIVE DYSKINESIA; URINARY HESITANCY; WITHDRAWAL SYNDROME;

EID: 27144511136     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.chi.0000177329.69462.5f     Document Type: Letter

References (5)

1. Campbell M, Armenteros JL, Malone RP, Adams PB, Eisenberg ZW, Overall JE (1997), Neuroleptic-related dyskinesias in autistic children; a prospective longitudinal study. J Am Acad Child Adolesc Psychiatry 36:835-843
2. Kumra S, Jacobsen L, Lenane M, Smith A, Lee P, Malanga CJ, et al. (1998), Case series: spectrum of neuroleptic-induced movement disorders and extrapyramidal side effects in childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 37:221-227
3. Rapoport J, Connors C, Reatig N (1985), Rating scales and assessment instruments for use in pediatric psychopharmacology research. Psychopharmacol Bull 21:713-111
4. Richardson MA, Bevans ML, Read LL, Read LL, Chao HM, Clelland JD, et al. (2003), Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men. Am J Psychiatry 160:(6):1117-1124
5. Simpson GM, Angus JWS (1970), A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 212(suppl 44):11-19